Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 253

1.

Prognosis terminal: truth-telling in the context of end-of-life care.

Rich BA.

Camb Q Healthc Ethics. 2014 Apr;23(2):209-19. doi: 10.1017/S0963180113000741.

PMID:
24534742
2.

Outdated dermatologic drug samples and obligations to the patient.

Wang J, Keller M.

J Am Acad Dermatol. 2013 Oct;69(4):643-5. doi: 10.1016/j.jaad.2013.04.034. Review. No abstract available.

PMID:
24034370
3.

Pharmacists' performance of clinical interventions during adherence support medication reviews.

Hatah E, Tordoff J, Duffull SB, Braund R.

Res Social Adm Pharm. 2014 Jan-Feb;10(1):185-94. doi: 10.1016/j.sapharm.2013.04.008. Epub 2013 May 17.

PMID:
23688540
5.

Catholic identity and charity care in the era of health reform.

Slosar JP, Repenshek MF, Bedford E.

HEC Forum. 2013 Jun;25(2):111-26. doi: 10.1007/s10730-013-9212-6.

PMID:
23553494
6.

COUNTERPOINT: Are surgeons ethically obligated to treat Medicare patients despite substantial reductions in reimbursement?

Acuff TE.

J Thorac Cardiovasc Surg. 2013 Jan;145(1):41-3. doi: 10.1016/j.jtcvs.2012.09.066. No abstract available.

PMID:
23244253
7.

POINT: Are surgeons ethically obligated to treat Medicare patients despite substantial reductions in reimbursement?

Verrier ED.

J Thorac Cardiovasc Surg. 2013 Jan;145(1):38-40. doi: 10.1016/j.jtcvs.2012.09.065. No abstract available.

PMID:
23244252
8.

Are surgeons ethically obligated to treat Medicare patients despite substantial reductions in reimbursement? Introduction.

Sade RM.

J Thorac Cardiovasc Surg. 2013 Jan;145(1):37. doi: 10.1016/j.jtcvs.2012.09.067. Epub 2012 Oct 23. No abstract available.

PMID:
23102682
9.

Justice and fairness: a critical element in U.S. health system reform.

Menzel PT.

J Law Med Ethics. 2012 Fall;40(3):582-97. doi: 10.1111/j.1748-720X.2012.00691.x.

PMID:
23061586
10.

The many vs. the few.

Loewenstein G.

Hastings Cent Rep. 2012 Sep-Oct;42(5):7-8; author reply 8-9. No abstract available.

PMID:
23050293
11.

The many vs. the few.

Wells RJ.

Hastings Cent Rep. 2012 Sep-Oct;42(5):7; author reply 8-9. No abstract available.

PMID:
23050292
12.

The many vs. the few.

Menzel PT.

Hastings Cent Rep. 2012 Sep-Oct;42(5):5-6; author reply 8-9. No abstract available.

PMID:
23050290
13.

How should we model rare disease allocation decisions?

London AJ.

Hastings Cent Rep. 2012 Jan-Feb;42(1):3. No abstract available.

PMID:
22616383
14.

Two dreams.

[No authors listed]

Hastings Cent Rep. 2012 Jan-Feb;42(1):2. No abstract available.

PMID:
22616382
15.
16.

Adverse selection and moral hazard in the provision of clinical trial ancillary care.

Richards MR, Helmchen LA.

Health Econ Policy Law. 2013 Apr;8(2):225-34. doi: 10.1017/S1744133112000072. Epub 2012 Apr 2.

PMID:
22464397
17.

The case for a parental duty to use preimplantation genetic diagnosis for medical benefit.

Malek J, Daar J.

Am J Bioeth. 2012;12(4):3-11. doi: 10.1080/15265161.2012.656798.

PMID:
22452463
18.

Why physicians ought to lie for their patients.

Tavaglione N, Hurst SA.

Am J Bioeth. 2012;12(3):4-12. doi: 10.1080/15265161.2011.652797.

PMID:
22416740
19.

Tim Jost of Washington & Lee and the duty of health reform.

[No authors listed]

Health Aff (Millwood). 2012 Feb;31(2):340. doi: 10.1377/hlthaff.2012.0031. No abstract available.

20.

Complex discharges and undocumented patients: growing ethical concerns.

Parsi K, Hossa N.

J Clin Ethics. 2012 Winter;23(4):299-307.

PMID:
23469690
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk